Caption Management, LLC Biomea Fusion, Inc. Call Options Transaction History

Caption Management, LLC

  • $5.74 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$4.23 - $10.1 $42,300 - $101,000
-10,000 Reduced 5.56%
170,000 $1.72 Million
Q2 2024

Aug 14, 2024
SELL
$4.14 - $15.3 $372,600 - $1.38 Million
-90,000 Reduced 33.33%
180,000 $810,000
Q1 2024

May 15, 2024
BUY
$13.92 - $19.5 $3.76 Million - $5.27 Million
270,000 New
270,000 $4.04 Million
Q2 2023

Aug 14, 2023
BUY
$21.66 - $41.8 $2.1 Million - $4.05 Million
97,000 Added 68.21%
239,200 $5.25 Million
Q1 2023

May 15, 2023
BUY
$6.8 - $32.35 $966,960 - $4.6 Million
142,200 New
142,200 $4.41 Million

Others Institutions Holding BMEA

# of Institutions
104
Shares Held
17.8M
Call Options Held
1.68M
Put Options Held
410K
View Full List

About Biomea Fusion, Inc.

BMEA Quotes by TradingView
  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $117M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email